About Carrie Lubitz, MD, MPH

Dr. Lubitz received her undergraduate and medical degrees at the University of Michigan. She completed general surgery training at New York Presbyterian Hospital/Weill-Cornell Medical College. During residency, she studied the genetic basis of thyroid cancer as a part of the NCI-Surgical Oncology Research Training Program. She then completed her clinical endocrine surgery fellowship in 2010 at the Massachusetts General Hospital and is now an Associate Professor of Surgery at the Harvard Medical School in the Division of Surgical Oncology, a member of the MGH Endocrine Surgery Unit, and a senior scientist at the Massachusetts General Hospital Institute for Technology Assessment. Through her clinical and translational research efforts, Dr. Lubitz, is influencing the care of thyroid cancer care. Dr. Lubitz has placed a high priority on appropriateness of care and patient-reported outcome measurement. This, in turn, has helped to assess the comparative effectiveness and improve the quality of care of patients with endocrine-related disorders. Dr. Lubitz is a current recipient of a K07 NIH young-investigator award and the Gilbert H. Daniels Innovative Research in Thyroid Cancers Award.

Clinical Interests:

Treats:

Locations

Surgical Oncology Associates
55 Fruit Street
Boston, MA 02114-2696
617-643-9473
Fax: 617-724-3895

Mass General/North Shore Center for Outpatient Care
104 Endicott Street
Danvers, MA 01923-3623
978-882-6883
Fax: 978-882-6848

Medical Education

  • MPH, Harvard University
  • MD, University of Michigan Medical School
  • Residency, New York Presbyterian Hospital Weill Cornell
  • Residency, University of Michigan Medical Center
  • Fellowship, Massachusetts General Hospital

American Board Certifications

  • Surgery, American Board of Surgery

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


Research

In addition to her clinical practice which focuses on both benign and malignant thyroid, parathyroid, and adrenal disease, Dr. Lubitz has clinical and translational research interests including prediction and decision-analytic modeling to assess the comparative effectiveness and improve the quality of care of patients with endocrine-related disorders. Her current projects involve identifying appropriate and effective diagnostic, surgical, and surveillance strategies for patients with primary hyperaldosteronism and thyroid cancer. She obtained a Master of Public Health through the Harvard School of Public Health and completed her fellowship in the Dana-Farber/Harvard Cancer Center Program in Cancer Outcomes Research Training in 2013. She continues as a senior scientist at the MGH Institute for Technology Assessment.

Publications